Gary Ingenito
Chief Tech/Sci/R&D Officer at CATALYST PHARMACEUTICALS, INC.
Net worth: 819 173 $ as of 2024-03-30
Gary Ingenito active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2015-05-31 | - |
| General Counsel | - | - |
Career history of Gary Ingenito
Former positions of Gary Ingenito
| Companies | Position | Start | End |
|---|---|---|---|
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 2005-01-31 | 2008-02-28 |
| General Counsel | 2005-01-31 | 2008-02-28 | |
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 2003-09-30 | 2004-12-31 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | General Counsel | - | - |
| Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | - | - |
| ONTRAK, INC. | Chief Tech/Sci/R&D Officer | 2011-04-10 | - |
Training of Gary Ingenito
| Thomas Jefferson University | Doctorate Degree |
| The Johns Hopkins University | Undergraduate Degree |
| University of Miami | Graduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Statistics
International
| United States | 10 |
| Canada | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| General Counsel | 3 |
| Corporate Officer/Principal | 2 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ONTRAK, INC. | Health Services |
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Commercial Services |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
| Sandoz Pharmaceuticals Corp. |
- Stock Market
- Insiders
- Gary Ingenito
- Experience
